Treatment of immune disorders with anti-CD70 antibody
    12.
    发明授权
    Treatment of immune disorders with anti-CD70 antibody 有权
    用抗CD70抗体治疗免疫疾病

    公开(公告)号:US08647624B2

    公开(公告)日:2014-02-11

    申请号:US12016814

    申请日:2008-01-18

    IPC分类号: A61K39/395 C07K16/28

    摘要: Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunosuppressive without conjugation to a therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering to a subject the CD70-binding agent.

    摘要翻译: 公开了CD70结合剂,例如抗CD70抗体和衍生物,其诱导细胞毒性,细胞抑制或免疫抑制而不与治疗剂缀合,以及包含抗体或衍生物的药物组合物和试剂盒。 还公开了用于治疗和预防表达CD70的癌症和免疫学疾病的方法,包括向受试者施用CD70-结合剂。

    Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders
    17.
    发明申请
    Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders 审中-公开
    抗CD20抗体 - 药物共轭物,用于治疗癌症和免疫疾病

    公开(公告)号:US20050180972A1

    公开(公告)日:2005-08-18

    申请号:US10632151

    申请日:2003-07-30

    CPC分类号: A61K47/6851 A61K47/6849

    摘要: The present invention relates to methods and compositions for the treatment of CD20-expressing cancers and immune disorders involving CD20-expressing cells. The present methods comprise administering to a subject an anti CD20 antibody-drug conjugate that has a high potency and/or is capable of internalizing into CD20-expressing cells. The present invention further provides pharmaceutical compositions and kits comprising such conjugates. The present invention yet further provides methods of and compositions relating to combination therapy of cancer and immune disorders involving CD20-expressing cells using the anti-CD20 antibody-drug conjugates of the invention.

    摘要翻译: 本发明涉及用于治疗表达CD20的癌症和涉及CD20表达细胞的免疫疾病的方法和组合物。 本发明的方法包括向受试者施用具有高效力和/或能够内化成CD20表达细胞的抗CD20抗体 - 药物偶联物。 本发明还提供了包含这种缀合物的药物组合物和试剂盒。 本发明还进一步提供了使用本发明的抗CD20抗体 - 药物共轭物的癌症和涉及CD20表达细胞的免疫疾病的组合疗法的方法和组合物。